AstraZeneca (AZN) names Roche's (RHHBY.OB) Pascal Soriot as its new CEO to replace David...

|About: AstraZeneca Group plc (AZN)|By:, SA News Editor

AstraZeneca (AZN) names Roche's (RHHBY.OB) Pascal Soriot as its new CEO to replace David Brennan, who retired on June 1. Interim AstraZeneca CEO Simon Lowth will resume his position as CFO. Soriot has been the COO of Roche's pharmaceuticals division since 2010, prior to which he was CEO of Genentech and led its merger with Roche. (PR)